|
|
Article: Research and Markets: Commercial Insight: Cardiovascular and Metabolic Market Overview Diabetes to the Fore as Generics Hit Primary Care Markets.
- Article from:
- Business Wire
- Article date:
- February 25, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/80e15a/commercial_insight) has announced the addition of the "Commercial Insight: Cardiovascular and Metabolic Market Overview Diabetes to the Fore as Generics Hit Primary Care Markets" report to their offering.
Antidiabetic therapies is expected to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2017. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major ...